@article{Varian_2024,
 author = {Varian, Frances and Dick, Jennifer and Battersby, Christian and Roman, Stefan and Ablott, Jenna and Watson, Lisa and Binmahfooz, Sarah and Zafar, Hamza and Colgan, Gerry and Cannon, John and Suntharalingam, Jay and Lordan, Jim and Howard, Luke and McCabe, Colm and Wort, John and Price, Laura and Church, Colin and Hamilton, Neil and Armstrong, Iain and Hameed, Abdul and Hurdman, Judith and Elliot, Charlie and Condliffe, Robin and Wilkins, Martin and Webb, Alastair and Adlam, David and Benza, Ray L. and Rahimi, Kazem and Shojaei‐Shahrokhabadi, Mohadeseh and Lin, Nan X. and Wason, James M. S. and McIntosh, Alasdair and McConnachie, Alex and Middleton, Jennifer T. and Thompson, Roger and Kiely, David G. and Toshner, Mark and Rothman, Alexander},
 doi = {10.1002/pul2.12337},
 issn = {2045-8940},
 journal = {Pulmonary Circulation},
 month = {January},
 number = {1},
 publisher = {Wiley},
 title = {Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies},
 url = {http://dx.doi.org/10.1002/pul2.12337},
 volume = {14},
 year = {2024}
}

